Carol Moore: Daily

As policing faces a crisis of trust, a veteran leader is recognized for a career spent building bridges. A look at Dr. Alexander's impact and what it means.

Coupang's debut on the Fortune Global 500 isn't just about revenue; it's a story of how strategic AI investment and logistics mastery are redrawing the map of global trade.

A new study shows Therabody's recovery devices can erase the halftime performance drop. Is this the future of how athletes prepare for the second half?

With a new CEO and CFO, Sumo Logic is betting its future on 'agentic AI,' aiming to transform security and cloud operations from reactive to autonomous.

With the appointment of Anthony Anzevino, Druva is making a strategic play to dominate the critical, emerging market for protecting AI-powered enterprises.

The shift to usage-based pricing is seductive, but scaling it is treacherous. A new guide reveals why back-office operations are the real key to growth.

An Australian biotech's breakthrough study on fucoidan, a seaweed compound, offers a safe, clinically-proven new option for men suffering from BPH.

Immersion's revenue soars post-BNED deal, but profits plummet. Can a haptics innovator thrive while managing an education giant and keep investors happy?

The 'Remembering Our Fallen' memorial comes to NJ, but the story is bigger: it reveals a powerful, collaborative system built to honor and support veterans.

PropertyAdvice.ai's new no-login, no-subscription platform offers instant virtual staging, making professional listing visuals accessible to all. But can it balance convenience with transparency?

The UK clinical brand, backed by L'Oréal and science, enters Sephora Canada. Can its CSA philosophy and flagship retinal serum conquer a crowded market?

As vocal strain becomes the hidden cost of remote work, a new free tool called Voicelyt offers a 30-second 'Voice Score' to track your vocal health.

Samsung Bioepis's latest report reveals a thriving biosimilar market, yet deep-seated policy debates over the 340B program threaten to disrupt growth.

Atombit and Medallia are forging a new European alliance, betting that the fusion of AI consulting and a top-tier platform can finally quantify experience.

With a new veteran-led sales team, Crush Security aims to upend the reseller market with its AI-driven 'Super VAR' model. Is this the future for CISOs?

With two new strategic leaders from the worlds of fintech and consumer subscriptions, Malwarebytes is pivoting hard from malware-fighting to all-encompassing digital life protection.

Beyond CO2, a potent gas threatens our climate. A new Chinese technology offers a 'near-zero' emissions solution, providing a blueprint for the world.

The global ice cream chain is rapidly expanding in Thailand, but is its strategy of deep community engagement a genuine partnership or a masterclass in PR?

City of Hope's new trial, funded by ARPA-H, uses DNA mapping to predict immunotherapy success, promising a new era of personalized care for lung cancer.

In Nevada County, a new partnership is using an advanced EHR to bridge the gap from incarceration to community, a model for integrating care and rebuilding lives.